Table 2 Treatment recommendations for clinical scenarios without consensus
Scenario without consensus | Recommended treatment options (number of centers) |
|---|---|
Single lymph node recurrence Fit patient Favorable tumor characteristics | 43% SBRT (n = 6) 29% Pelvic RT + ADT (n = 4) 7% SBRT + ADT (n = 1) 7% SBRT or pelvic RT (n = 1) 7% SBRT +/−ADT or pelvic RT + ADT (n = 1) 7% Surgery and/or pelvic RT + ADT (n = 1) |
Four lymph node recurrences Fit patient Favorable tumor characteristics | 43% ADT (n = 6) 36% Pelvic RT + ADT (n = 5) 14% SBRT (n = 2) 7% Pelvic RT (n = 1) |